![Page 1: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/1.jpg)
MITOCHONDRIAL DISEASE
Amel Karaa, MD Mitochondrial Disease Program
Massachusetts General Hospital
![Page 2: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/2.jpg)
Disclosures & Disclaimers• United Mitochondrial Disease Foundation Research Grant
• North American Mitochondrial Disease Consortium (RDCRN/NIH)
• Advisory Board of:• Mitochondrial Medicine Society• MitoAction• Stealth BioTherapeutics
![Page 3: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/3.jpg)
• Overview of the mitochondria• Overview of mitochondrial function & genetics• Overview of mitochondrial disease:
SymptomsDiagnosis Management
Outline:
![Page 4: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/4.jpg)
http://biology.tutorvista.com/animal-and-plant-cells/mitochondria.html
Overview: the mitochondria1 to 1000s/cell
![Page 5: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/5.jpg)
Overview: The mitochondria
Vafai et al. Nature 2013:491, 374–383
![Page 6: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/6.jpg)
Overview: the mitochondria
Modified from Wallace D. Cold Spring Harbor Symposia on Quantitative Biology, Volume LXXVI
![Page 7: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/7.jpg)
Nat Rev Genet. 2012 December ; 13(12): 878–890
Overview: the mitochondriaThe electron transport chain
![Page 8: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/8.jpg)
Overview: the mitochondria
mtDNAnDNA
The Mitochondrial Organelle
Bi-genomic Input
![Page 9: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/9.jpg)
Unique mtDNA genetics• Maternal inheritance
Overview of mtDNA
![Page 10: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/10.jpg)
Unique mitochondrial genetics• Maternal inheritance• Double stranded circular DNA
Overview of mtDNA
} 16,569 bp} Encodes 37 proteins:
} 22 tRNAs} 13 respiratory chain peptides} 2 ribosomal
} 5–10 copies/mitochondrion, 100–1000s/cell} Limited DNA repair (↑mutation rate)
![Page 11: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/11.jpg)
Unique mitochondrial genetics• Maternal inheritance• Double stranded circular DNA• Random segregation
Threshold expression and Heteroplasmy
Overview of mtDNA
![Page 12: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/12.jpg)
Overview of mtDNA
http://clinicalgate.com/the-human-microbiome/
![Page 13: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/13.jpg)
Unique mitochondrial genetics• Maternal inheritance• Double stranded circular DNA• Random segregation, Threshold expression and
Heteroplasmy
Overview of mtDNA
jcb.rupress.org
![Page 14: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/14.jpg)
The EMBO Journal VOL 32 | NO 1 | 2013
Overview of nDNA
![Page 15: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/15.jpg)
Mendelian inheritance patterns
• Autosomal recessive (most common)• Autosomal dominant• X-linked
Overview of nDNA
Sporadic/De novo
Hundreds of genes
![Page 16: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/16.jpg)
• Prevalence in children 6.2/100,000*,• At least 1 in 4,300 of adults will develop mitochondrial disease
Overview of mitochondrial disease
* D. Skladal, J. Halliday, D. R. Thorburn, Brain 126, 1905–1912 (2003).
![Page 17: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/17.jpg)
Overview of mitochondrial disease
• Any age – infancy to adulthood• Multi-organ dysfunction• Variable severity• Progressive• Episodic
‘…any organ, any symptom, any age’
![Page 18: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/18.jpg)
Episodic Phenotype
TIME
OBSERVABLE
DYSFUNCTION
normal
aging mild
severe
moderate OrganFailure
Metabolic Stress à
Overview of mitochondrial disease
![Page 19: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/19.jpg)
0 10 20 30 40 50 (%)0102030(%)
EncephalopathyMyopathy
Myocardiopathy
Exercise intolerance
Kidney disease
Leigh syndrome
Ophthalmoplegia
Intestinal disease
DysmorphyBone marrow dysfunction
Retinopathy
Peripheral neuropathyAtaxia
MERRF/MELASDeafness
Alpers syndrome
Diabetes
Optic atrophy
Liver disease
Adults (n = 390) Children (n = 220)SIMD/NAMA :Courtesy of Dr A Lombes Hopital La SalpétrièreUniversité Paris VI
Overview of mitochondrial disease
![Page 20: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/20.jpg)
Most common reasons for referralChildren Adults
HypotoniaSeizuresDevelopmental delayElevated lactate levelsAbnormal MRI imagesLiver diseaseFailure to thriveGI dysmotility
Fatigue +++Shortness of breath, air hungerMuscle painGI dysmotilityDysautonomia/POTSMultiple symptoms in many organ system that do not seem to be related
Overview of mitochondrial disease
![Page 21: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/21.jpg)
Overview of mitochondrial diseaseWhen should I suspect mitochondrial disease?
• Atypical features• Multisystemic involvement• Recurrent setbacks or “flare-ups” occur with stressors
![Page 22: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/22.jpg)
DiMauro S, Schon EA. Am J Med Genet 2001;106(1): 18–26
Overview of mtDNA disease
![Page 23: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/23.jpg)
Overview of mtDNA disease
• MELAS: Mitochondrial Encephalomyopathy, Lactic Acidosis and Strokes
• MERRF: Myoclonic Epilepsy with Ragged Red Fibers• LHON: Leber’s Hereditary Optic Neuropathy• KSS/PEO: Kearns Sayre syndrome/Progressive external ophthalmoplegia.
![Page 24: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/24.jpg)
MELAS:
• Symptoms before age 40• Neurosensory hearing loss• Migraine headaches• Peripheral neuropathy• Myopathy • Depression and other psychiatric disorders
Overview of mtDNA disease
![Page 25: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/25.jpg)
MELAS:• Endocrine• Cardiac involvement• Kidney dysfunction
Overview of mtDNA disease
![Page 26: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/26.jpg)
MELAS:• Polygenetic disorder caused by at least 29 mutations in
mtDNA• A3243G (tRNA gene): most common mutation (80%)• Overlap with MERRF
Overview of mtDNA disease
![Page 27: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/27.jpg)
Overview of mtDNA disease
Symmetric signal prolongation in both occipital lobes involving the medial aspects.
à IV Arginine Protocol
MELAS:
![Page 28: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/28.jpg)
MERRF:• Ataxia, weakness and dementia• Sensorineural hearing loss• Exercise intolerance, seizures, dystonia• Optic atrophy, pigmentary retinopathy, ophthalmoparesis• Cardiomyopathy• Multiple lipomas
Overview of mtDNA disease
![Page 29: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/29.jpg)
MERRF:
Overview of mtDNA disease
The most common mutation (> 80%): m.8344A>G
![Page 30: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/30.jpg)
LHON:
• Degeneration of retinal ganglion cells and their axons
• Acute or subacute loss of central vision
• Affects predominantly young adult males
Overview of mtDNA disease
http://www.lhon.org/lhon/LHON.html
![Page 31: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/31.jpg)
Overview of mtDNA diseaseDNA deletion syndromes/PEO:
http://www.neurology.org/content/51/6/1525.2/F4.medium.gif
![Page 32: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/32.jpg)
Overview of mtDNA diseaseDNA deletion syndromes/KSS:Clinical triad– Onset < 20 yrs– CPEO– Retinal degenerationOther features– Cerebellar ataxia– Sensorineural deafness– Complete heart block– Elevated CSF protein (100 mg/dl)– Endocrinopathies– Nearly always sporadic
http://www.stlukeseye.com/conditions/RetinitisPigmentosa.html
![Page 33: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/33.jpg)
The EMBO Journal VOL 32 | NO 1 | 2013
Overview of nDNA
![Page 34: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/34.jpg)
Overview of nDNA
Clinical Presentation of Mitochondrial Diseases in Children with PIND Christopher M Verity et al.
2493 cases of progressive ID112 (69 males, 43 females) with mitochondrial diseases
Ages birth to 14 yearsMedian age 12moMost with non-specific:
Developmental delayHypotoniaFailure to thriveSeizures
Mortality was high 36%Abnormal CSF lactate 77%Abnormal MRI (increased basal ganglia signal) 60%
![Page 35: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/35.jpg)
Primary mitochondrial disease Vs.
Secondary mitochondrial dysfunction
Common in cancer, chronic diseases, Parkinson’s disease, ALS, Pompe, other neurodegenerative disorders, and normal aging.
Overview of 2ry mitochondrial disease
![Page 36: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/36.jpg)
Overview of 2ry mitochondrial disease
Lancet 2012; 379: 1825–34
![Page 37: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/37.jpg)
Diagnostic Evaluation: The problem• Nonspecific symptoms• There is no universally accepted diagnostic algorithm for
mitochondrial disorders• There is no gold standard diagnostic method.• Enzyme (ETC) testing may produce false positive and
false negative results.• Molecular testing is positive in 25-45% of the cases at
best.
![Page 38: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/38.jpg)
Diagnostic Evaluation
Morava et al Neurology 2006
![Page 39: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/39.jpg)
Annals of Medicine, 2013; 45: 4–16
Diagnostic Evaluation: Other
![Page 40: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/40.jpg)
Diagnostic EvaluationIMAGING TESTING
Leigh MELAS KSS ETC defMNGIEMERRF– Bilateral deep gray [putamen, GP, caudate]
– Metabolic stroke [non-vascular territory]– Diffuse white matter abnormalities– Lactate on MRS (abnl choline, NAA)– Cerebral and/or cerebellar volume loss E.Grant
![Page 41: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/41.jpg)
Diagnostic EvaluationEM
RRF
Histochemistry
COX SDH
![Page 42: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/42.jpg)
Molecular Testing: ? New Gold standard• mtDNA
• Screen point mutations • Whole genome screen • Deletion/duplication analysis • Depletion
• nDNA• Specific gene selection • Screening – NGS
• panel• whole exome/whole genome or dual genome analysis
Diagnostic Evaluation
![Page 43: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/43.jpg)
Treatment and Management
• No single treatment. • Management is tailored for each individual.
Lifestyle changes are very important and can be effective.
![Page 44: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/44.jpg)
Treatment and ManagementEnergy balance equation:
Minimize energy losses Avoid physical stresses
Emotional stressesAdequate rest
Optimize energy gains. Sleep
NutritionExercise
![Page 45: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/45.jpg)
Treatment and Management
§Avoid toxins: • Drugs, cigarette smoking, alcohol
§“Mitochondrial cocktail”:• Variety of vitamin and cofactor supplementation.
![Page 46: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/46.jpg)
Therapy in trials:
• EPI-743:- Small molecule (Edison Pharmaceuticals) for the treatment of Leigh syndrome, Pearson syndrome and other ETC deficiency.
• MTP-131 Bendavia:- Peptide (Stealth Biotherapeutics) that targets mitochondria
for the treatment of mitochondrial myopathy.
Treatment and Management
![Page 47: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/47.jpg)
Therapy in trials:
• RTA- 408:- Small molecule (Reata Pharmaceuticals) for the treatment of mitochondrial myopathy.
• RP-103:- Cysteamine (Raptor Pharmaceuticles) for children with
confirmed mitochondrial disease.• Ultragenix:
- Triheptanoin
Treatment and Management
![Page 48: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/48.jpg)
Science. 2015, VOL 349 ISSUE 6255
Prevention: Mitochondrial Donations
![Page 49: Karaa Child neurology talk 10 29 2015 · 2015-10-29 · • MTP-131 Bendavia:-Peptide (Stealth Biotherapeutics) that targets mitochondria for the treatment of mitochondrial myopathy](https://reader033.vdocuments.us/reader033/viewer/2022050601/5fa893867d75301fe30a1f28/html5/thumbnails/49.jpg)
• Thank you, and any questions?
Amel Karaa, MDAdult Mitochondrial Disease Program
Massachusetts General Hospital